Request for Nominations to the Advisory Council on Alzheimer's Research, Care, and Services, 22008-22009 [2017-09545]

Download as PDF 22008 Federal Register / Vol. 82, No. 90 / Thursday, May 11, 2017 / Notices ANNUAL BURDEN ESTIMATES Number of respondents Instrument Post-Expenditure Reporting Form ................................................................... Use of Post-Expenditure Reporting Form as Part of the Intended Use Plan Estimated Total Annual Burden Hours: 6,272. In compliance with the requirements of the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. Chap 35), the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 330 C Street SW., Washington DC 20201. Attn: ACF Reports Clearance Officer. Email address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Robert Sargis, Reports Clearance Officer. [FR Doc. 2017–09581 Filed 5–10–17; 8:45 am] BILLING CODE 4184–24–P asabaliauskas on DSK3SPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Request for Nominations to the Advisory Council on Alzheimer’s Research, Care, and Services Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. ACTION: Notice. AGENCY: VerDate Sep<11>2014 16:52 May 10, 2017 Jkt 241001 56 56 The Secretary of HHS established the Advisory Council to provide advice and consultation to the Secretary on how to prevent or reduce the burden of Alzheimer’s disease and related dementias on people with the disease and their caregivers. The Secretary signed the charter establishing the Advisory Council on May 23, 2011. HHS is soliciting nominations for seven (7) new non-Federal members of the Advisory Council to replace the seven members whose terms will end September 30th, 2017. Nominations should include the nominee’s contact information (current mailing address, email address, and telephone number) and current curriculum vitae or resume. DATES: Submit nominations by email or USPS mail before COB on June 16, 2017. ADDRESSES: Nominations should be sent by email to Rohini Khillan at rohini.khillan@hhs.gov; or sent by USPS mail to: Rohini Khillan, Office of the Assistant Secretary for Planning and Evaluation, Room 424E, Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690–5932, rohini.khillan@hhs.gov. SUPPLEMENTARY INFORMATION: The Advisory Council on Alzheimer’s Research, Care, and Services meets quarterly to discuss programs that impact people with Alzheimer’s disease and related dementias and their caregivers. The Advisory Council makes recommendations to Congress and the Secretary of Health and Human Services about ways to reduce the financial impact of Alzheimer’s disease and related dementias and to improve the health outcomes of people with these conditions. The Advisory Council also provides feedback on a National Plan for Alzheimer’s disease. On an annual basis, the Advisory Council evaluates the implementation of the recommendations through an updated National Plan. The National Alzheimer’s Project Act, Public Law 111–375 (42 U.S.C. 11225), requires that the Secretary of Health and Human Services (HHS) establish the Advisory Council on Alzheimer’s Research, Care, and Services. The Advisory Council is SUMMARY: PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Number of responses per respondent 1 1 Average burden hours per response 110 2 Total burden ours 6,160 112 governed by provisions of Public Law 92–463 (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. The Advisory Council consists of 22 members. Ten members will be designees from Federal agencies including the Centers for Disease Control and Prevention, Administration for Community Living, Centers for Medicare and Medicaid Services, Indian Health Service, National Institutes of Health, National Science Foundation, Department of Veterans Affairs, Food and Drug Administration, Agency for Healthcare Research and Quality, and the Health Resources and Services Administration. The Advisory Council also consists of 12 non-federal members selected by the Secretary who fall into 6 categories: Dementia caregivers (2), health care providers (2), representatives of State health departments (2), researchers with dementia-related expertise in basic, translational, clinical, or drug development science (2), voluntary health association representatives (2), and dementia patient advocates, including an advocate who is currently living with the disease (2). The member living with the disease serves a 2-year term. At this time, the Secretary shall appoint one member for each category, to replace the seven members whose terms will end on September 30th, 2017, for a total of seven (7) new members to the Council. After receiving nominations, the Secretary, with input from his staff, will make the final decision, and the new members will be announced soon after. Members shall be invited to serve 4-year terms, except that any member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term. The member living with the disease will serve a 2-year term. A member may serve after the expiration of the member’s term until a successor has taken office. Members will serve as Special Government Employees. E:\FR\FM\11MYN1.SGM 11MYN1 Federal Register / Vol. 82, No. 90 / Thursday, May 11, 2017 / Notices Dated: May 3, 2017. John R. Graham, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2017–09545 Filed 5–10–17; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings asabaliauskas on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorder and Stroke Special Emphasis Panel; Blueprint Neurotherapeutics Network (BPN) Small Molecule Drug Discovery and Development. Date: June 5, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Monaco, 700 F Street NW., Washington, DC 20001. Contact Person: Joel Saydoff, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892–9529, (301) 496–9223, Joel.saydoff@nih.gov. Name of Committee: Neurological Science Training Initial Review Group; NST–1 Subcommittee. Date: June 5–6, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: The Embassy Suites Alexandria Old Town, 1900 Diagonal Road, Alexandria, VA 22314. Contact Person: William Benzing, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892–9529, (301) 496–0660, Benzing@mail.nih.gov. Name of Committee: Neurological Science Training Initial Review Group; NST–2 Subcommittee. Date: June 19, 2017. Time: 8:00 a.m. to 6:00 p.m. VerDate Sep<11>2014 16:52 May 10, 2017 Jkt 241001 Agenda: To review and evaluate grant applications. Place: The Warwick Allerton Hotel, 701 North Michigan Avenue, Chicago, IL 60611. Contact Person: Elizabeth Webber, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892–9529, (301) 496–1917, webberre@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) 22009 (Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: May 4, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–09489 Filed 5–10–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: May 5, 2017. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2017–09597 Filed 5–10–17; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Pain Mobile Remote Pain Management System (Topic 160; Phase II, 4434, 4435). Date: May 9, 2017. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892– 9550, (301) 827–5702, lf33c.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Center for Scientific Review; Notice of Closed Meetings Name of Committee: Center for Scientific Review Special Emphasis Panel; Collaborative Applications: Adult Psychopathology. Date: June 6, 2017. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Marines’ Memorial Club & Hotel, 609 Sutter Street, San Francisco, CA 94102. Contact Person: Serena Chu, Ph.D., Scientific Review Officer, BBBP IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD 20892, 301–500– 5829, sechu@csr.nih.gov. Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Neurotoxicology and Alcohol Study Section. Date: June 7–8, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Avenue NW., Washington, DC 20037. Contact Person: Jana Drgonova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5213, Bethesda, MD 20892, 301–827–2549, jdrgonova@mail.nih.gov. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Modeling and Analysis of Biological Systems Study Section. E:\FR\FM\11MYN1.SGM 11MYN1

Agencies

[Federal Register Volume 82, Number 90 (Thursday, May 11, 2017)]
[Notices]
[Pages 22008-22009]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Request for Nominations to the Advisory Council on Alzheimer's 
Research, Care, and Services

AGENCY: Office of the Assistant Secretary for Planning and Evaluation, 
Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Secretary of HHS established the Advisory Council to 
provide advice and consultation to the Secretary on how to prevent or 
reduce the burden of Alzheimer's disease and related dementias on 
people with the disease and their caregivers. The Secretary signed the 
charter establishing the Advisory Council on May 23, 2011. HHS is 
soliciting nominations for seven (7) new non-Federal members of the 
Advisory Council to replace the seven members whose terms will end 
September 30th, 2017. Nominations should include the nominee's contact 
information (current mailing address, email address, and telephone 
number) and current curriculum vitae or resume.

DATES: Submit nominations by email or USPS mail before COB on June 16, 
2017.

ADDRESSES: Nominations should be sent by email to Rohini Khillan at 
rohini.khillan@hhs.gov; or sent by USPS mail to: Rohini Khillan, Office 
of the Assistant Secretary for Planning and Evaluation, Room 424E, 
Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690-5932, 
rohini.khillan@hhs.gov.

SUPPLEMENTARY INFORMATION: The Advisory Council on Alzheimer's 
Research, Care, and Services meets quarterly to discuss programs that 
impact people with Alzheimer's disease and related dementias and their 
caregivers. The Advisory Council makes recommendations to Congress and 
the Secretary of Health and Human Services about ways to reduce the 
financial impact of Alzheimer's disease and related dementias and to 
improve the health outcomes of people with these conditions. The 
Advisory Council also provides feedback on a National Plan for 
Alzheimer's disease. On an annual basis, the Advisory Council evaluates 
the implementation of the recommendations through an updated National 
Plan. The National Alzheimer's Project Act, Public Law 111-375 (42 
U.S.C. 11225), requires that the Secretary of Health and Human Services 
(HHS) establish the Advisory Council on Alzheimer's Research, Care, and 
Services. The Advisory Council is governed by provisions of Public Law 
92-463 (5 U.S.C. Appendix 2), which sets forth standards for the 
formation and use of advisory committees.
    The Advisory Council consists of 22 members. Ten members will be 
designees from Federal agencies including the Centers for Disease 
Control and Prevention, Administration for Community Living, Centers 
for Medicare and Medicaid Services, Indian Health Service, National 
Institutes of Health, National Science Foundation, Department of 
Veterans Affairs, Food and Drug Administration, Agency for Healthcare 
Research and Quality, and the Health Resources and Services 
Administration.
    The Advisory Council also consists of 12 non-federal members 
selected by the Secretary who fall into 6 categories: Dementia 
caregivers (2), health care providers (2), representatives of State 
health departments (2), researchers with dementia-related expertise in 
basic, translational, clinical, or drug development science (2), 
voluntary health association representatives (2), and dementia patient 
advocates, including an advocate who is currently living with the 
disease (2). The member living with the disease serves a 2-year term.
    At this time, the Secretary shall appoint one member for each 
category, to replace the seven members whose terms will end on 
September 30th, 2017, for a total of seven (7) new members to the 
Council. After receiving nominations, the Secretary, with input from 
his staff, will make the final decision, and the new members will be 
announced soon after. Members shall be invited to serve 4-year terms, 
except that any member appointed to fill a vacancy for an unexpired 
term shall be appointed for the remainder of such term. The member 
living with the disease will serve a 2-year term. A member may serve 
after the expiration of the member's term until a successor has taken 
office. Members will serve as Special Government Employees.


[[Page 22009]]


    Dated: May 3, 2017.
John R. Graham,
Acting Assistant Secretary for Planning and Evaluation.
[FR Doc. 2017-09545 Filed 5-10-17; 8:45 am]
BILLING CODE 4150-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.